Old Web
English
Sign In
Acemap
>
authorDetail
>
Molero M. T. Labarta
Molero M. T. Labarta
Internal medicine
Medicine
Gastroenterology
Polycythemia vera
Ruxolitinib
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
LEVELS OF BCL2 EXPRESSION AT POST-INDUCTION AND AT COMPLETE REMISSION IMPACT THE OUTCOME IN AML AND MAY IDENTIFY THOSE PATIENTS THAT WOULD BENEFIT OF BCL2 INHIBITORS: PB1689
2019
C. Bilbao
Rodríguez C. Medina
Sánchez S. Sosa
Florido Y. Ortega
Saez M. D. L. N. Perdomo
González J. M. Martín
González E. Pérez
R. Stuckey
R. Fernandez
V Peri
Molero M. T. Labarta
Gómez M. T. Casares
Show All
Source
Cite
Save
Citations (0)
RUXOLITINIB IN POLYCYTHEMIA VERA PATIENTS: RESPONSE DIFFERENCES BETWEEN IN HYDROXYUREA INTOLERANT AND RESISTANT PATIENTS: PB2233
2019
González E. Pérez
F. FernándezFuertes
Raya J. M. Sánchez
K. Mayani
Tapia M. Torres
Saez M. D. L. N. Perdomo
Sánchez S. Sosa
Florido Y. Ortega
Bilbao C. Sieyro
R. Stuckey
Molero M. T. Labarta
Gómez M. T. Casares
Show All
Source
Cite
Save
Citations (0)
GENE EXPRESSION PROFILE IN PRIMARY MYELOFIBROSIS: ROLE OF ASXL1: PB2193
2019
Sánchez S. Sosa
Bilbao C. Sieyro
Florido Y. Ortega
González E. Pérez
Saez M. D. L. N. Perdomo
R. Stuckey
Santana G. Santana
Molero M. T. Labarta
Loro J. F. Ferrer
Gómez M. T. Casares
Show All
Source
Cite
Save
Citations (0)
1